Mutational and immunologic Landscape in malignant Salivary Gland Tumors harbor the potential for novel therapeutic strategies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mutational and immunologic Landscape in malignant Salivary Gland Tumors harbor the potential for novel therapeutic strategies

Published:2022-02 Issue: Volume:170 Page:103592
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Witte Hanno M.,Gebauer Niklas^ORCID,Steinestel Konrad

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference252 articles.

1. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands;Agulnik;J. Clin. Oncol.,2007

2. The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities;Alame;Theranostics,2020

3. Systemic therapy in metastatic salivary gland carcinomas: a pathology-driven paradigm?;Alfieri;Oral Oncol.,2017

4. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs;Allard;Clin. Cancer Res.,2013

5. The ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targets;Allard;Immunol. Rev.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current diagnosis and treatment of salivary gland-type tumors of the lung;Japanese Journal of Clinical Oncology;2023-11-28

2. The Therapeutic Landscape of Salivary Gland Malignancies—Where Are We Now?;International Journal of Molecular Sciences;2022-11-28

3. Identification of Fusion Genes and Targets for Genetically Matched Therapies in a Large Cohort of Salivary Gland Cancer Patients;Cancers;2022-08-27

4. The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition;Journal of Cancer Research and Clinical Oncology;2022-07-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3